Geospace Technologies Corporation (NASDAQ:GEOS) tinted gains of +3.84% (+0.43 points) to US$11.63. The volume of 0.24 Million shares climbed down over an trading activity of 87.79 Million shares. EPS ratio determined by looking at last 12 month figures is -3.58. Over the same time span, the stock marked US$18.71 as its best level and the lowest price reached was US$9.18. The corporation has a market cap of US$158.28 Million.

Geospace Technologies Corporation (NASDAQ:GEOS)’s earnings per share has been growing at a -29.1 percent rate over the past 5 year when average revenue increase was noted as -17.4 percent. The return on equity ratio or ROE stands at -24.6 percent while most common profitability ratio return on investment (ROI) was -29.2 percent. The company’s institutional ownership is monitored at 82.8 percent. The company’s net profit margin has achieved the current level of -66.6 percent and possesses -19.2 percent gross margin.

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) is worth US$17.55 Million and has recently risen 3.82% to US$0.84. The latest exchange of 0.19 Million shares is below its average trading activity of 113.84 Million shares. The day began at US$0 but the price moved to US$0 at one point during the trading and finally capitulating to a session high of US$0. The stock tapped a 52-week high of US$2.85 while the mean 12-month price target for the shares is US$1.5.

Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 21, and a price to sales ratio of 87.74. For the past 5 years, the company’s revenue has grown -50.3%, while the company’s earnings per share has grown 11.7%. With an institutional ownership near 7.1%, it carries an earnings per share ratio of -0.68.

Inside Look At Analysts Reviews

Latest analyst recommendations could offer little help to investors. The stock is a Buy among 0 brokerage firms polled by Factset Research. At present, 1 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 0 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 3.